JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaudhry, A.
Right arrow Articles by Granneman, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaudhry, A.
Right arrow Articles by Granneman, J. G.

Perinatal changes in the coupling of beta 1- and beta 3 adrenergic receptors to brown fat adenylyl cyclase

A Chaudhry, KN Lahners and JG Granneman

Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan.

The stimulation of adenylyl cyclase by catecholamines in neonatal brown adipose tissue (BAT) is markedly biphasic, suggesting the existence of receptors that have both high and low affinities for catecholamines. The identities of these receptors were examined by comparing responses in neonatal BAT membranes to those of Chinese hamster ovary cells which had been transfected to express the cloned rat beta 1 and beta 3 receptors. The results from these experiments indicate that high- affinity stimulation of adenylyl cyclase by catecholamines in BAT is mediated by beta 1 receptors, as evidenced by the potencies of norepinephrine and isoproterenol at this receptor and the potent blockade of the receptor by alprenolol. The low-affinity catecholamine receptor appears to be the beta 3 receptor, as indicated by the low potency of catecholamine agonists and the inability of low concentrations of alprenolol to block this activity. Furthermore, this receptor, like the cloned rat beta 3 receptor, was antagonized by (-)-4- (3-t-butylamino-2-hydroxypropoxy)benzimidazol-2-one (CGP 12177) and was stimulated by (R',R')-4-(2-[(2[(3-chlorophenyl)-2- hydroxyethyl]amino)propyl]phenyl)phenoxyacetic acid (BRL 37344). These results indicate that both beta 1 and beta 3 receptors couple to adenylyl cyclase in BAT and that activation of adenylyl cyclase in neonatal BAT is mediated primarily by beta 3 receptors. Beta 3 receptors were also clearly detected in weanling BAT with the beta 3- selective agonist BRL 37344. However, when catecholamines were used to stimulate activity, the activation of adenylyl cyclase by beta 1 receptors, which occurred at low concentrations of catecholamines, obscured the activation of adenylyl cyclase by beta 3 receptors, which occurred only at high concentrations.

Volume 261, Issue 2, pp. 633-637, 05/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Beitzel, M. N. Sillence, and G. S. Lynch
beta-Adrenoceptor signaling in regenerating skeletal muscle after beta-agonist administration
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E932 - E940.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. CANNON and J. NEDERGAARD
Brown Adipose Tissue: Function and Physiological Significance
Physiol Rev, January 1, 2004; 84(1): 277 - 359.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. T. Auman, F. J. Seidler, C. A. Tate, and T. A. Slotkin
Are developing beta -adrenoceptors able to desensitize? Acute and chronic effects of beta -agonists in neonatal heart and liver
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R205 - R217.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. A. Konkar, Z. Zhu, and J. G. Granneman
Aryloxypropanolamine and Catecholamine Ligand Interactions with the beta 1-Adrenergic Receptor: Evidence for Interaction with Distinct Conformations of beta 1-Adrenergic Receptors
J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 923 - 932.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. A. Konkar, Y. Zhai, and J. G. Granneman
beta 1-Adrenergic Receptors Mediate beta 3-Adrenergic-Independent Effects of CGP 12177 in Brown Adipose Tissue
Mol. Pharmacol., February 1, 2000; 57(2): 252 - 258.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Zhao, B. Cannon, and J. Nedergaard
Thermogenesis is beta 3- but not beta 1-adrenergically mediated in rat brown fat cells, even after cold acclimation
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1998; 275(6): R2002 - R2011.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. G. Granneman, K. N. Lahners, and Y. Zhai
Agonist Interactions with Chimeric and Mutant beta 1- and beta 3-Adrenergic Receptors: Involvement of the Seventh Transmembrane Region in Conferring Subtype Specificity
Mol. Pharmacol., May 1, 1998; 53(5): 856 - 861.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Deng, M. Moinat, L. Curtis, A. Nadakal, F. Preitner, O. Boss, F. Assimacopoulos-Jeannet, J. Seydoux, and J.-P. Giacobino
Effects of {beta}-Adrenoceptor Subtype Stimulation on obese Gene Messenger Ribonucleic Acid and on Leptin Secretion in Mouse Brown Adipocytes Differentiated in Culture
Endocrinology, February 1, 1997; 138(2): 548 - 552.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics.